Skip to main content
Clinical Trials/CTRI/2022/09/046022
CTRI/2022/09/046022
Completed
Phase 2

A comparative evaluation of osseous regeneration in the surgical extraction socket of mandibular third molars using a semisolid simvastatin formulation vs PRF (Platelet Rich Fibrin) - A Split Mouth Study

Dr Monika Gupta0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Monika Gupta
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 1, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Monika Gupta

Eligibility Criteria

Inclusion Criteria

  • Surgical site should be free of infection.
  • Patient requiring extraction bilaterally of impacted mandibular third molars.
  • The site should be where primary wound closure can be achieved.

Exclusion Criteria

  • Patient having connective tissue/bleeding disorders.
  • Patient who have undergone radiation/chemotherapy to head and neck region.
  • Patients allergic to drug simvastatin.
  • Patient having uncontrolled diseases of systemic nature.
  • Patients with fibro\-osseous diseases of bone.
  • Any pathology associated with apical region of mandibular third molar.
  • Patients on immuno\-supressants and/or on anticoagulants.

Outcomes

Primary Outcomes

Not specified

Similar Trials